Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance

Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Hexaminolevulinate (HAL) is an optical imaging agent used with fluorescence cystoscopy (FC) for the detection of non-muscle-invasive bladder cancer (NMIBC). Guidelines from the European Association of Urology (EAU) and a recent, more detailed European expert consensus statement agree that HAL-FC has a role in improving detection of NMIBC and provide recommendations on situations for its use. Since the publication of the EAU guidelines and the European consensus statement, new evidence on the efficacy of HAL-FC in reducing recurrence of NMIBC, compared with white light cystoscopy (WLC), have been published.
Original languageEnglish
JournalScandinavian Journal of Urology and Nephrology
Issue number2
Pages (from-to)108-16
Number of pages9
Publication statusPublished - 2012

    Research areas

  • Aminolevulinic Acid, Consensus, Cystoscopy, Europe, Fluorescence, Humans, Photosensitizing Agents, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Urinary Bladder Neoplasms

ID: 36847693